Pharmaceutical / Drug Definition :
May reversibly inhibit acetylcholinesterase, increasing concentration of acetylcholine (necessary for nerve impulse transmission) in brain synapses.
FDA Label Requirements and Exceptions
Galantamine Hydrobromide
FDA Import Information
Galantamine Hydrobromide
FDA Detentions
Galantamine Hydrobromide (Galantamine Hydrobromide Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Galantamine Hydrobromide (Galantamine Hydrobromide Suppliers)
- Processors Galantamine Hydrobromide
- Repackers Galantamine Hydrobromide
- Relabelers Galantamine Hydrobromide
- Exporters Galantamine Hydrobromide
- Importers Galantamine Hydrobromide
For more information about Galantamine Hydrobromide, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
